Implementation of Tele-Exercise for Management of Knee Osteoarthritis in Older Rural Primary Care Patients
1 other identifier
interventional
15
1 country
1
Brief Summary
Knee osteoarthritis (OA) is highly prevalent and a leading cause of pain that limits physical functioning in older adults. Clinical practice guidelines recommend physical exercise for managing symptoms of knee OA. As a result, several evidence-based exercise programs have been implemented in community centers. However, access to these programs is severely limited in rural settings. Considering that rural communities have a higher disease burden and higher proportion of older adults than non-rural areas, there is a critical need to (1) adapt evidence-based exercise programs for remote delivery to increase access for rural older adults and (2) develop pathways to implement exercise programs in rural health care systems that consistently reach and engage patients with knee OA. Accordingly, we aim to engage rural primary care practices (including medical directors, clinicians, and staff) to develop a clinical pathway that refers patients to an evidence-based exercise program, called Enhance Fitness® (EF), which we have adapted for remote delivery (tele-EF). Enhance Fitness is a group exercise program that is recommended by the CDC for OA management. It is available in over 800 sites nationally and is covered by Medicare Advantage plans, but it is generally not available in rural communities. In addition, we will assess the feasibility and acceptability of implementing the clinical pathway that identifies physically inactive older patients with knee OA, facilitates exercise prescription, and streamlines referral to tele-EF in a rural primary care clinic over a 5-month period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable knee-osteoarthritis
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2021
CompletedFirst Posted
Study publicly available on registry
January 13, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedJanuary 13, 2021
January 1, 2021
12 months
January 8, 2021
January 10, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Active minutes per day
Average number of minutes spent in moderate to vigorous physical activity as measured by the activPAL accelerometer
Change from Baseline Active Minutes at 12 weeks
Secondary Outcomes (2)
Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function 8-item Short Form
Change from Baseline PROMIS Physical Function score at 12 weeks
Knee injury and Osteoarthritis Outcome Score (KOOS) Physical Function Subscale
Change from Baseline KOOS Physical Function Subscale score at 12 weeks
Study Arms (1)
Tele-EF
EXPERIMENTALTele-EnhanceFitness
Interventions
Livestream, instructor-led tele-exercise classes, involving balance, endurance, and strength training
Eligibility Criteria
You may qualify if:
- Age ≥65 years
- Community-dwelling
- English-speaking
- Physician diagnosed knee osteoarthritis
- Physically inactive as determined by the 2-item Physical Activity Vital Sign questionnaire
You may not qualify if:
- Cognitive impairment determined by a Mini Montreal Cognitive Assessment score of \<11
- Significant, non-corrected visual or hearing impairment
- Plans to move out of the area in the next 6 months
- Cancer requiring treatment (except for non-melanoma skin cancer) in the past 6 months
- Heart attack in the past 6 months
- Stroke in the past 6 months
- Hip fracture in the past 6 months
- Hip/knee replacement in the past 6 months
- Spinal surgery in the past 6 months
- Heart surgery in the past 6 months
- Deep vein thrombosis in the past 6 months
- Pulmonary embolus in the past 6 months
- Hospitalization within the last month
- ≥3 falls within the past month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Washington
Seattle, Washington, 98195-6540, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kushang V Patel, PhD
University of Washington
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate Professor
Study Record Dates
First Submitted
January 8, 2021
First Posted
January 13, 2021
Study Start
March 1, 2021
Primary Completion
February 18, 2022
Study Completion
February 28, 2022
Last Updated
January 13, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will share
The investigators recognize that data sharing leads to the promotion of science. We intend to publish the results of the proposed study and will make data available to investigators upon request (following publication). The final dataset will include demographic, clinical, and behavioral data on 15 older adults followed over a 3-month period. Even though the final dataset will be stripped of identifiers prior to release for sharing, we believe that the possibility of deductive disclosure of subjects with unusual characteristics remains. For these reasons, we propose to make the data and associated documentation available to users under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.